Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.000 CAD
3.52 M CAD
25.39 M CAD
117.54 M
About Microbix Biosystems Inc.
Sector
Industry
CEO
Cameron L. Groome
Website
Headquarters
Mississauga
Founded
1988
ISIN
CA59501P1045
FIGI
BBG000CB00R1
Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. It operates through the Antigens, QAPs and DxTM, and Other segments. The Antigens, QAPs and DxTM segment includes the development, manufacturing and sales of products relating to the medical diagnostics industry. The Other segment deals with the development and commercialization of novel and proprietary products or technologies such as Kinlytic. The company was founded by William J. Gastle in 1988 and is headquartered in Mississauga, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MBX is 0.245 CAD — it has increased by 6.52% in the past 24 hours. Watch Microbix Biosystems Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange Microbix Biosystems Inc. stocks are traded under the ticker MBX.
MBX stock has risen by 2.08% compared to the previous week, the month change is a −16.95% fall, over the last year Microbix Biosystems Inc. has showed a −34.67% decrease.
We've gathered analysts' opinions on Microbix Biosystems Inc. future price: according to them, MBX price has a max estimate of 0.50 CAD and a min estimate of 0.50 CAD. Watch MBX chart and read a more detailed Microbix Biosystems Inc. stock forecast: see what analysts think of Microbix Biosystems Inc. and suggest that you do with its stocks.
MBX stock is 11.36% volatile and has beta coefficient of −0.34. Track Microbix Biosystems Inc. stock price on the chart and check out the list of the most volatile stocks — is Microbix Biosystems Inc. there?
Yes, you can track Microbix Biosystems Inc. financials in yearly and quarterly reports right on TradingView.
Microbix Biosystems Inc. is going to release the next earnings report on Dec 18, 2025. Keep track of upcoming events with our Earnings Calendar.
Microbix Biosystems Inc. revenue for the last quarter amounts to 3.47 M CAD, despite the estimated figure of 3.60 M CAD. In the next quarter, revenue is expected to reach 3.60 M CAD.
MBX net income for the last quarter is −1.64 M CAD, while the quarter before that showed 20.66 K CAD of net income which accounts for −8.05 K% change. Track more Microbix Biosystems Inc. financial stats to get the full picture.
No, MBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Microbix Biosystems Inc. EBITDA is 2.24 M CAD, and current EBITDA margin is 21.73%. See more stats in Microbix Biosystems Inc. financial statements.
Like other stocks, MBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Microbix Biosystems Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Microbix Biosystems Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Microbix Biosystems Inc. stock shows the sell signal. See more of Microbix Biosystems Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.